Literature DB >> 25521922

Diagnostic methods and recommendations for the cerebral creatine deficiency syndromes.

Joseph F Clark1, Kim M Cecil2.   

Abstract

Primary care pediatricians and a variety of specialist physicians strive to define an accurate diagnosis for children presenting with impairment of expressive speech and delay in achieving developmental milestones. Within the past two decades, a group of disorders featuring this presentation have been identified as cerebral creatine deficiency syndromes (CCDS). Patients with these disorders were initially discerned using proton magnetic resonance spectroscopy of the brain within a magnetic resonance imaging (MRI) examination. The objective of this review is to provide the clinician with an overview of the current information available on identifying and treating these conditions. We explain the salient features of creatine metabolism, synthesis, and transport required for normal development. We propose diagnostic approaches for confirming a CCDS diagnosis. Finally, we describe treatment approaches for managing patients with these conditions.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25521922     DOI: 10.1038/pr.2014.203

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  16 in total

Review 1.  Laboratory diagnostic approaches in metabolic disorders.

Authors:  Ruben Bonilla Guerrero; Denise Salazar; Pranoot Tanpaiboon
Journal:  Ann Transl Med       Date:  2018-12

2.  Quantifying global-brain metabolite level changes with whole-head proton MR spectroscopy at 3T.

Authors:  Matthew S Davitz; William E Wu; Brian J Soher; James S Babb; Ivan I Kirov; Jeffrey Huang; Girish Fatterpekar; Oded Gonen
Journal:  Magn Reson Imaging       Date:  2016-08-28       Impact factor: 2.546

3.  Dietary guanidinoacetic acid does not accumulate in the brain of healthy men.

Authors:  Sergej M Ostojic; Jelena Ostojic
Journal:  Eur J Nutr       Date:  2017-12-19       Impact factor: 5.614

4.  SLC gene mutations and pediatric neurological disorders: diverse clinical phenotypes in a Saudi Arabian population.

Authors:  Ali Mir; Montaha Almudhry; Fouad Alghamdi; Raidah Albaradie; Mona Ibrahim; Fatimah Aldurayhim; Abdullah Alhedaithy; Mushari Alamr; Maryam Bawazir; Sahar Mohammad; Salma Abdelhay; Shahid Bashir; Yousef Housawi
Journal:  Hum Genet       Date:  2021-11-19       Impact factor: 4.132

5.  Diagnostic yield from routine metabolic screening tests in evaluation of global developmental delay and intellectual disability.

Authors:  Hilary Vallance; Graham Sinclair; Bojana Rakic; Sylvia Stockler-Ipsiroglu
Journal:  Paediatr Child Health       Date:  2020-12-19       Impact factor: 2.253

6.  Perspective: Creatine, a Conditionally Essential Nutrient: Building the Case.

Authors:  Sergej M Ostojic; Scott C Forbes
Journal:  Adv Nutr       Date:  2022-02-01       Impact factor: 11.567

7.  Global brain metabolic quantification with whole-head proton MRS at 3 T.

Authors:  Ivan I Kirov; William E Wu; Brian J Soher; Matthew S Davitz; Jeffrey H Huang; James S Babb; Mariana Lazar; Girish Fatterpekar; Oded Gonen
Journal:  NMR Biomed       Date:  2017-07-05       Impact factor: 4.044

Review 8.  Neurometabolic disorders: Five new things.

Authors:  Michèl A Willemsen; Inga Harting; Ron A Wevers
Journal:  Neurol Clin Pract       Date:  2016-08

9.  Creatine Levels in Patients with Phenylketonuria and Mild Hyperphenylalaninemia: A Pilot Study.

Authors:  Elvira Verduci; Maria Teresa Carbone; Laura Fiori; Claudia Gualdi; Giuseppe Banderali; Claudia Carducci; Vincenzo Leuzzi; Giacomo Biasucci; Gian Vincenzo Zuccotti
Journal:  Life (Basel)       Date:  2021-05-06

10.  Oxidative phosphorylation in creatine transporter deficiency.

Authors:  Shizhe Li; Simona Bianconi; Jan Willem van der Veen; An Dang Do; JoEllyn Stolinski; Kim M Cecil; Fady Hannah-Shmouni; Forbes D Porter; Jun Shen
Journal:  NMR Biomed       Date:  2020-09-29       Impact factor: 4.478

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.